Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00578851 · ClinicalTrials.gov registry record
A Clinical Investigation of the C2a-Taper™ Acetabular System
A clinical trial, sponsored by Biomet Orthopedics.
- Completed
- Registry status
- 28
- Enrollment target
NCT00578851: Completed study, sponsored by Biomet Orthopedics.
NCT00578851 is a clinical trial that has completed, run by Biomet Orthopedics. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00578851 has completed, sponsored by Biomet Orthopedics.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The objective of this study is to gather clinical and survivorship information for the C2a-Taper™ Acetabular System, a ceramic-on-ceramic hip articulating system.
Interventions
- DEVICE C2a - Taper™ Acetabular System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-04 |
| Est. Completion | 2015-10 |
What the finished NCT00578851 record still lists
NCT00578851 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which C2a - Taper™ Acetabular System is the first listed.
NCT00578851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00578851 about?
NCT00578851 is a clinical study titled "A Clinical Investigation of the C2a-Taper™ Acetabular System". The objective of this study is to gather clinical and survivorship information for the C2a-Taper™ Acetabular System, a ceramic-on-ceramic hip articulating system.
What is the current status of trial NCT00578851?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2006-04. Estimated completion is 2015-10.
What interventions are being tested in trial NCT00578851?
The interventions under investigation include: C2a - Taper™ Acetabular System (DEVICE).
Who is sponsoring clinical trial NCT00578851?
This trial is sponsored by Biomet Orthopedics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia